Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of liposomal siRNA in subjects with hypercholesterolemia; the trial has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Liposomal siRNA

Snippet

Sponsor: Arbutus Biopharma Corporation | Conditions: Hypercholesterolemia | Phase 1 | Status: TERMINATED